Appia Bio

Appia Bio

Appia Bio is a biotechnology startup dedicated to discovering and developing scalable allogeneic cell therapies to increase access to cancer treatment. Market:Cell therapy has brought dramatic improvements in efficacy and durable remission rates in certain...
Avesta76 Therapeutics

Avesta76 Therapeutics

  Avesta76 is focused on a target that has the potential to treat every type of tumor. Market: Avesta76's therapies will address the need for safe and effective treatments across multiple cancers. This is a market with 17 million annual diagnoses, 10 million deaths,...
Capacity Bio, Inc.

Capacity Bio, Inc.

 Capacity Bio is developing the most comprehensive and advanced mitophagy therapeutics and development platform for the purpose of restoring mitochondria quality control in disease. Market:Capacity Bio's lead focus is neurodegeneration and muscular disorders,...
CDR3 Therapeutics, Inc.

CDR3 Therapeutics, Inc.

CDR3 develops stem cell-based immunotherapies to cure HPV-related cancers using chimeric antigen receptors or chronic viral infections using T cell receptors. Market:Today, we lack cures for most virus-related cancers and chronic viral infections, especially from...
CBD Research Institute

CBD Research Institute

CBD Research Institute was launched as the first company in the CBD space led by founders with medical training and ties to the medical research community. The company thus serves as a unique hub uniting scientists, medical researchers, patients, and consumers toward...